CRISPR Gene Editing Industry Analysis: Companies, Competitors & Outlook 2027

Overview of the Global CRISPR Gene Editing Industry:

The Global CRISPR Gene Editing market is projected to experience substantial growth between 2022 and 2027, driven by digital transformation, innovation in service delivery, and expanding demand. With a forecasted CAGR of 18.24% during the forecast period, i.e., 2022-27.

This report offers an in-depth analysis of the key drivers, challenges, competitive landscape, and future outlook — helping businesses, investors, and stakeholders make informed decisions.

Market Size & Forecast (2022–2027)

Base Year: 2021
Forecast Period: 2022-27
Estimated CAGR (2022-27): 18.24%

Key Market Driver (What’s Driving CRISPR Gene Editing Sector Growth?)

Prevalence of Genetic Disorders & Use of Genome Editing to Boost the Market Growth - The prevalence of genetic disorders has been increasing over the years across the globe. Some of the most prevalent are thalassemia, down syndrome, cystic fibrosis, and sickle cell anemia. For every 10,000 live births globally, 4.4 cases of thalassemia are reported. According to the Thalassemia International Federation, about 7% of the population experience hemoglobin-associated conditions, around 70% have sickle cell anemia, and the remaining develop thalassemia or other blood disorders.

Further, in recent years, CRISPR gene editing demand has been driven by significant breakthrough scientific research across various dimensions to treat hereditary disorders. As per the research publication of the New England Journal of Medicine, 2020, CRISPR gene therapies depicted positive results for treating sickle cell anemia & beta-thalassemia. In addition, ongoing clinical trials for the gene correction in homo sapiens to treat genetic disorders further augmented the growth of the CRISPR Gene Editing market globally.

In case you missed it, we are currently revising our reports. Click on the "request sample report" button to get the latest research data with forecast for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.

("Engage with our team using your official business email to unlock full access and priority support.")

Top Companies in the CRISPR Gene Editing Market

Here’s a snapshot of key players leading innovation and market share:

Abcam Inc.
Applied StemCell Inc.
Agilent Technologies Inc.
Cellecta Inc.
CRISPR Therapeutics AG
Thermo Fischer Scientific Inc.
GeneCopoeia Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies Inc.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies Inc.
Rockland Immunochemicals Inc.
Others (Synthego Corporation, ToolGen Inc., etc.)

The market is highly fragmented, with a mix of and regional players competing for market share. To Learn More About the Trends Impacting the Future of Top 10 Companies in Premium CRISPR Gene Editing Market

Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/crispr-gene-editing-market.html

CRISPR Gene Editing Market Segmentation Analysis

-By Product Type

CRISPR Products
CRISPR Services

Here, the CRISPR Products type dominates the Global CRISPR Gene Editing market and is anticipated to remain dominant during the forecast period, owing to the presence of CRISPR pooled libraries that consist of thousands of plasmids based on library type, species, and library size.

-By Application

Agriculture
Industrial
Biomedical
Others

Of them all, the biomedical segment held a considerable share in the CRISPR Gene Editing market on account of tremendous development in cell & gene therapy, drug discovery, and diagnostic domains across the globe.

-By End User

Academic Institutions and Research Centers
Biotechnology Companies
Contract Research Organizations (CROs)
Pharmaceutical & Biopharmaceutical Companies

Geographical Analysis

-By Region

North America
South America
Europe
Middle East & Africa
Asia Pacific

Of all the regions, North America is home to many legacies & emerging companies in the field of CRISPR gene editing that are currently investigating drug candidates in clinical research.

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/crispr-gene-editing-market.html

Methodology Behind the Report

This research combines qualitative and quantitative methods, including:

Expert interviews
Proprietary forecasting models
Financial and trade databases
Government and institutional data

Forecasts are validated using top-down and bottom-up approaches to ensure accuracy and reliability.

Frequently Asked Questions About the CRISPR Gene Editing Market

What is the growth rate of the CRISPR Gene Editing market from 2022–2027?
Which segment are expected to dominate market?
Who are the top companies and what strategies being they using?
What are the key risks and challenges in this industry?
How can businesses prepare for future trends?

Other Reports:

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Media Contact:

Company Name: MarkNtel Advisors

Email: [email protected]

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh - 201301, India